Cite

HARVARD Citation

    Mace, T. et al. (n.d.). Anti-IL-6 and PD-L1 antibody combination therapy reduces tumor progression in murine models of pancreatic cancer. Journal for immunotherapy of cancer. p. . [Online]. 
  
Back to record